{"id":70796,"date":"2025-10-10T02:30:18","date_gmt":"2025-10-10T02:30:18","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/70796\/"},"modified":"2025-10-10T02:30:18","modified_gmt":"2025-10-10T02:30:18","slug":"novo-nvo-plans-to-make-obesity-pill-available-online-once-approved","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/70796\/","title":{"rendered":"Novo (NVO) Plans to Make Obesity Pill Available Online Once Approved"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody__3UcBa\" data-component=\"paragraph\"><a href=\"https:\/\/www.bloomberg.com\/quote\/NOVOB:DC\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Novo Nordisk A\/S<\/a> plans to launch its new obesity pill on telehealth sites like Ro and <a href=\"https:\/\/www.bloomberg.com\/quote\/WGHTQ:US\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">WeightWatchers<\/a> as soon as it\u2019s approved. The move is an attempt to win back market share from rival <a href=\"https:\/\/www.bloomberg.com\/quote\/LLY:US\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Eli Lilly and Co.<\/a>, which has pulled ahead in the weight-loss drug race.<\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody__3UcBa\" data-component=\"paragraph\">\u201cThere\u2019s certainly awareness of Ozempic, and increasingly with Wegovy \u2014 and we can build on that,\u201d said Dave Moore, Novo\u2019s US operations chief in an interview at Bloomberg\u2019s New York headquarters. Making the pill available online, where so many consumers are purchasing weight-loss shots already, \u201callows us to to have the awareness at a different level,\u201d he said. <\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk A\/S plans to launch its new obesity pill on telehealth sites like Ro and WeightWatchers as&hellip;\n","protected":false},"author":2,"featured_media":70797,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[72,47476,18645,1813,1523,103,397,396,61,44393,60,4320,18644,29293,4269,24297],"class_list":["post-70796","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-business","tag-dave-moore","tag-eli-lilly-co","tag-europe","tag-government","tag-health","tag-health-care","tag-healthcare","tag-ie","tag-industrials","tag-ireland","tag-new-york","tag-novo-nordisk-a-s-b","tag-pharmaceutical","tag-regulation","tag-telemedicine"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/70796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=70796"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/70796\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/70797"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=70796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=70796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=70796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}